Basic Information | Post buying leads | Suppliers |
[2,2]bipyridinyl
4-amino-N-(4,6-dimethyl-2-pyrimidinyl)benzenesulfonamide sodium salt
Conditions | Yield |
---|---|
Stage #1: [2,2]bipyridinyl; copper(ll) sulfate pentahydrate In water Heating; Stage #2: 4-amino-N-(4,6-dimethyl-2-pyrimidinyl)benzenesulfonamide sodium salt In water for 4h; Reflux; | 89% |
triphenyltetrazolium chloride
4-amino-N-(4,6-dimethyl-2-pyrimidinyl)benzenesulfonamide sodium salt
Conditions | Yield |
---|---|
In methanol; water at 20℃; for 2h; | 86% |
Conditions | Yield |
---|---|
Stage #1: 8-quinolinol; copper(ll) sulfate pentahydrate In water Heating; Stage #2: 4-amino-N-(4,6-dimethyl-2-pyrimidinyl)benzenesulfonamide sodium salt In water for 4h; Reflux; | 81% |
water
cadmium(II) acetate
4-amino-N-(4,6-dimethyl-2-pyrimidinyl)benzenesulfonamide sodium salt
Conditions | Yield |
---|---|
In water Cd(II) acetate in distd. water added dropwise with stirring; stirred (18 h, room temp.); filtered off; air dried; crystd. (NH4OH-H2O, 3:9); elem. anal.; | 80% |
Conditions | Yield |
---|---|
Stage #1: cobalt(II) perchlorate hexahydrate; bromazepam In water for 2h; Reflux; Stage #2: 4-amino-N-(4,6-dimethyl-2-pyrimidinyl)benzenesulfonamide sodium salt In water for 4h; Reflux; | 74.9% |
4-amino-N-(4,6-dimethyl-2-pyrimidinyl)benzenesulfonamide sodium salt
Conditions | Yield |
---|---|
In water for 2h; Reflux; | 73% |
Conditions | Yield |
---|---|
In water Zn(II) acetate in distd. water added dropwise with stirring; stirred (18 h, room temp.); filtered off; air dried; crystd. (NH4OH-H2O, 1:9); elem. anal.; | 71% |
Conditions | Yield |
---|---|
Stage #1: nickel(II) perchlorate hexahydrate; bromazepam In water for 2h; Reflux; Stage #2: 4-amino-N-(4,6-dimethyl-2-pyrimidinyl)benzenesulfonamide sodium salt In water for 4h; Reflux; | 67.8% |
(2-trimethylethylsilylethoxy)methyl chloride
4-amino-N-(4,6-dimethyl-2-pyrimidinyl)benzenesulfonamide sodium salt
Conditions | Yield |
---|---|
In acetonitrile at 20℃; for 20h; | 65% |
2,2'-biquinoline
4-amino-N-(4,6-dimethyl-2-pyrimidinyl)benzenesulfonamide sodium salt
Conditions | Yield |
---|---|
In methanol for 2h; Reflux; | 64.3% |
The Sulfamethazine sodium salt, with the CAS registry number 1981-58-4, is also known as . It belongs to the product categories of Antibiotics for Research and Experimental Use; Biochemistry; Sulfonamides (Antibiotics for Research and Experimental Use). Its EINECS registry number is 217-840-0. This chemical's molecular formula is C12H14N4NaO2S and molecular weight is 301.3199. Its IUPAC name is called sodium (4-aminophenyl)sulfonyl-(4,6-dimethylpyrimidin-2-yl)azanide. This chemical's classification code is Drug / Therapeutic Agent. Meanwhile, this product should be stored at 2-8 °C.
Physical properties of Sulfamethazine sodium salt: (1)H-Bond Donor: 1; (2)H-Bond Acceptor: 4; (3)Rotatable Bond Count: 3; (4)Exact Mass: 300.065691; (5)MonoIsotopic Mass: 300.065691; (6)Topological Polar Surface Area: 95.3; (7)Heavy Atom Count: 20; (8)Formal Charge: 0; (9)Complexity: 383; (10)Isotope Atom Count: 0; (11)Defined Atom StereoCenter Count: 0; (12)Undefined Atom StereoCenter Count: 0; (13)Defined Bond StereoCenter Count: 0; (14)Undefined Bond StereoCenter Count: 0; (15)Covalently-Bonded Unit Count: 2.
When you are using this chemical, please be cautious about it. This chemical may cause damage to health. It is harmful if swallowed. Whenever you will contact it, please wear suitable protective clothing.
You can still convert the following datas into molecular structure:
(1)Canonical SMILES: CC1=CC(=NC(=N1)[N-]S(=O)(=O)C2=CC=C(C=C2)N)C.[Na+]
(2)InChI: InChI=1S/C12H13N4O2S.Na/c1-8-7-9(2)15-12(14-8)16-19(17,18)11-5-3-10(13)4-6-11;/h3-7H,13H2,1-2H3;/q-1;+1
(3)InChIKey: NGIVTUVVBWOTNT-UHFFFAOYSA-N
The toxicity data is as follows:
Organism | Test Type | Route | Reported Dose (Normalized Dose) | Effect | Source |
---|---|---|---|---|---|
mouse | LD50 | intraperitoneal | 974mg/kg (974mg/kg) | Journal of Pharmacology and Experimental Therapeutics. Vol. 81, Pg. 17, 1944. | |
mouse | LD50 | intravenous | 605mg/kg (605mg/kg) | Minerva Medica. Vol. 52, Pg. 1789, 1961. | |
mouse | LD50 | oral | 1165mg/kg (1165mg/kg) | Minerva Medica. Vol. 52, Pg. 1789, 1961. | |
mouse | LD50 | subcutaneous | 699mg/kg (699mg/kg) | Minerva Medica. Vol. 52, Pg. 1789, 1961. |